Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Treatment of total exudative retinal detachment due to central retinal vein occlusion by intravitreal bevacizumab in a patient with p-ANCA vasculitis.

Ferencz JR, Rosen E, Tam G, Gilady G, Rubowich A, Assia EI, Korzets Z.

Clin Ophthalmol. 2007 Sep;1(3):347-51.

2.

Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study.

Rouvas A, Petrou P, Vergados I, Pechtasides D, Liarakos V, Mitsopoulou M, Ladas I.

Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1609-16. doi: 10.1007/s00417-009-1138-y. Epub 2009 Jul 16.

PMID:
19609550
3.

Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion.

Spaide RF, Chang LK, Klancnik JM, Yannuzzi LA, Sorenson J, Slakter JS, Freund KB, Klein R.

Am J Ophthalmol. 2009 Feb;147(2):298-306. doi: 10.1016/j.ajo.2008.08.016. Epub 2008 Oct 17.

PMID:
18929354
4.

Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.

Cekiç O, Chang S, Tseng JJ, Barile GR, Weissman H, Del Priore LV, Schiff WM, Weiss M, Klancnik JM Jr.

Retina. 2005 Oct-Nov;25(7):846-50.

PMID:
16205562
5.

Bilateral nonsimultaneous visual loss associated with idiopathic arterial pulmonary hypertension.

Nehemy MB, Torquetti L, Vasconcelos-Santos DV.

Retin Cases Brief Rep. 2010 Spring;4(2):154-7. doi: 10.1097/ICB.0b013e318199b0f9.

PMID:
25390391
6.

Intravitreal bevacizumab for macular edema due to proton beam radiotherapy: Favorable results shown after eighteen months follow-up.

Loukianou E, Brouzas D, Georgopoulou E, Koutsandrea C, Apostolopoulos M.

Ther Clin Risk Manag. 2010 May 25;6:249-52.

7.

Interventions for central retinal vein occlusion: an evidence-based systematic review.

Mohamed Q, McIntosh RL, Saw SM, Wong TY.

Ophthalmology. 2007 Mar;114(3):507-19, 524. Review.

PMID:
17324695
8.

Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.

Feltgen N, Junker B, Agostini H, Hansen LL.

Ophthalmology. 2007 Apr;114(4):716-23. Epub 2006 Nov 30.

PMID:
17141322
9.
10.

Role of posterior vitreous detachment induced by intravitreal tissue plasminogen activator in macular edema with central retinal vein occlusion.

Murakami T, Takagi H, Ohashi H, Kita M, Nishiwaki H, Miyamoto K, Watanabe D, Sakamoto A, Yamaike N, Yoshimura N.

Retina. 2007 Oct;27(8):1031-7.

PMID:
18040240
11.

Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients.

Isola V, Pece A, Massironi C, Reposi S, Dimastrogiovanni F.

Clin Ophthalmol. 2013;7:455-60. doi: 10.2147/OPTH.S30156. Epub 2013 Mar 1.

12.

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion.

Gutiérrez JC, Barquet LA, Caminal JM, Mitjana, Almolda SP, Domènech NP, Goita OP, Caso MR, Ginebreda JA.

Clin Ophthalmol. 2008 Dec;2(4):787-91.

13.

Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment.

Houston SK, Shah NV, Decatur C, Lonngi M, Feuer W, Markoe AM, Murray TG.

Clin Ophthalmol. 2013;7:193-8. doi: 10.2147/OPTH.S37938. Epub 2013 Jan 22.

14.
15.
16.
17.

Advanced Coats' disease treated with intravitreal bevacizumab combined with laser vascular ablation.

Villegas VM, Gold AS, Berrocal AM, Murray TG.

Clin Ophthalmol. 2014 May 16;8:973-6. doi: 10.2147/OPTH.S62816. eCollection 2014.

18.

Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system.

Samuel MA, Equi RA, Chang TS, Mieler W, Jampol LM, Hay D, Yannuzzi LA.

Ophthalmology. 2007 Aug;114(8):1526-1529.e1.

PMID:
17678691
19.

Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.

Puche N, Glacet A, Mimoun G, Zourdani A, Coscas G, Soubrane G.

Acta Ophthalmol. 2012 Jun;90(4):357-61. doi: 10.1111/j.1755-3768.2010.01913.x. Epub 2010 Jun 29.

20.

TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENT.

Stanga PE, Jaberansari H, Bindra MS, Gil-Martinez M, Biswas S.

Retina. 2016 Jan;36(1):156-62. doi: 10.1097/IAE.0000000000000669.

PMID:
26355946
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk